Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00QLR
|
||||
| Former ID |
DNC008656
|
||||
| Drug Name |
(-)-DEBROMOFLUSTRAMINE B
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H30N2
|
||||
| Canonical SMILES |
CC(=CCC12CCN(C1N(C3=CC=CC=C23)CC=C(C)C)C)C
|
||||
| InChI |
1S/C21H30N2/c1-16(2)10-12-21-13-15-22(5)20(21)23(14-11-17(3)4)19-9-7-6-8-18(19)21/h6-11,20H,12-15H2,1-5H3
|
||||
| InChIKey |
NUWYFFDZPIGJJO-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
| PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
| Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
| Nicotinic acetylcholine receptor signaling pathway | |||||
| WikiPathways | Irinotecan Pathway | ||||
| References | |||||
| REF 1 | J Med Chem. 2008 Sep 11;51(17):5271-84. Epub 2008 Aug 8.Synthesis and biological evaluation of (-)- and (+)-debromoflustramine B and its analogues as selective butyrylcholinesterase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.